CTLA4 and central nervous system cancer: Multiple levels of suppression are produced by the upregulation of other immune checkpoint molecules in glioma-infiltrating lymphocytes, including TIM-3, LAG-3, VISTA, and cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) (17).